ACAD Insider Trading

Insider Ownership Percentage: 28.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $7,419,224.24

ACADIA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ACADIA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ACADIA Pharmaceuticals Share Price & Price History

Current Price: $14.91
Price Change: Price Decrease of -0.18 (-1.19%)
As of 06/14/2024 01:00 AM ET

This chart shows the closing price history over time for ACAD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ACADIA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2024Mark C. SchneyerCFOSell975$14.79$14,420.2534,564View SEC Filing Icon  
5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.3842,133View SEC Filing Icon  
5/2/2024James KiharaInsiderSell1,326$16.94$22,462.4414,370View SEC Filing Icon  
5/2/2024Mark C. SchneyerCFOSell3,503$16.94$59,340.8232,053View SEC Filing Icon  
5/2/2024Stephen R. DavisCEOSell11,427$16.94$193,573.38155,231View SEC Filing Icon  
4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.1638,796View SEC Filing Icon  
4/8/2024James KiharaInsiderSell1,790$17.87$31,987.3013,100View SEC Filing Icon  
4/8/2024Mark C. SchneyerCFOSell2,716$17.87$48,534.9228,742View SEC Filing Icon  
4/8/2024Stephen R. DavisCEOSell26,574$17.87$474,877.38144,267View SEC Filing Icon  
3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.0036,340View SEC Filing Icon  
3/27/2024Mark C. SchneyerCFOSell5,434$17.90$97,268.6026,183View SEC Filing Icon  
3/27/2024Stephen R. DavisCEOSell17,714$17.90$317,080.60118,842View SEC Filing Icon  
2/26/2024Brendan TeehanCOOSell624$24.67$15,394.0831,432View SEC Filing Icon  
2/26/2024James KiharaInsiderSell474$24.67$11,693.5811,391View SEC Filing Icon  
2/26/2024Mark C. SchneyerCFOSell772$24.67$19,045.2421,067View SEC Filing Icon  
2/26/2024Stephen R. DavisCEOSell5,577$24.67$137,584.59101,890View SEC Filing Icon  
1/8/2024Austin D KimEVPSell590$29.96$17,676.4046,901View SEC Filing Icon  
1/8/2024Brendan TeehanCOOSell731$29.96$21,900.7630,949View SEC Filing Icon  
1/8/2024Stephen R. DavisCEOSell3,732$29.96$111,810.7296,521View SEC Filing Icon  
12/15/2023James KiharaInsiderSell2,000$28.30$56,600.0011,025View SEC Filing Icon  
11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.4030,393View SEC Filing Icon  
11/20/2023James KiharaInsiderSell1,985$22.64$44,940.4013,025View SEC Filing Icon  
11/20/2023Mark C. SchneyerCFOSell5,108$22.64$115,645.1220,486View SEC Filing Icon  
10/6/2023Austin D KimEVPSell16,369$21.96$359,463.2445,857View SEC Filing Icon  
10/6/2023Stephen R. DavisCEOSell51,563$21.96$1,132,323.4889,131View SEC Filing Icon  
9/15/2023James KiharaInsiderSell2,000$25.88$51,760.0010,778View SEC Filing Icon  
8/21/2023Mark C. SchneyerCFOSell10,000$29.00$290,000.0015,682View SEC Filing Icon  
7/14/2023Stephen R. DavisCEOSell100,000$30.04$3,004,000.0036,695View SEC Filing Icon  
7/11/2023Stephen R. DavisCEOSell16,498$25.00$412,450.0091,799View SEC Filing Icon  
6/15/2023James KiharaInsiderSell2,000$24.15$48,300.009,144View SEC Filing Icon  
6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.0013,502View SEC Filing Icon  
6/8/2023Mark C. SchneyerCFOSell974$25.02$24,369.4822,824View SEC Filing Icon  
5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.7338,811,515View SEC Filing Icon  
5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.5024,356View SEC Filing Icon  
5/17/2023James KiharaInsiderSell5,947$22.50$133,807.5011,144View SEC Filing Icon  
5/17/2023Mark C. SchneyerCFOSell15,310$22.50$344,475.0021,905View SEC Filing Icon  
5/1/2023Austin D KimEVPSell917$21.18$19,422.0625,513View SEC Filing Icon  
5/1/2023Brendan TeehanCOOSell548$21.18$11,606.649,487View SEC Filing Icon  
5/1/2023Stephen R. DavisCEOSell7,806$21.18$165,331.08108,297View SEC Filing Icon  
4/10/2023James KiharaInsiderSell523$18.14$9,487.225,197View SEC Filing Icon  
4/6/2023Austin D KimEVPSell1,456$18.16$26,440.9623,425View SEC Filing Icon  
4/6/2023Brendan TeehanCOOSell1,751$18.16$31,798.168,468View SEC Filing Icon  
4/6/2023James KiharaInsiderSell701$18.16$12,730.164,231View SEC Filing Icon  
4/6/2023Mark C. SchneyerCFOSell1,916$18.16$34,794.567,477View SEC Filing Icon  
4/6/2023Stephen R. DavisCEOSell8,582$18.16$155,849.12100,478View SEC Filing Icon  
2/24/2023Austin D KimEVPSell803$18.78$15,080.3420,108View SEC Filing Icon  
2/24/2023Brendan TeehanCOOSell461$18.78$8,657.585,195View SEC Filing Icon  
2/24/2023James KiharaInsiderSell350$18.78$6,573.002,923View SEC Filing Icon  
2/24/2023Mark C. SchneyerCFOSell577$18.78$10,836.064,118View SEC Filing Icon  
2/24/2023Stephen R. DavisCEOSell3,851$18.78$72,321.7891,727View SEC Filing Icon  
1/12/2023Laura BregeDirectorSell12,500$18.25$228,125.00View SEC Filing Icon  
1/9/2023Austin D KimEVPSell589$17.13$10,089.5718,697View SEC Filing Icon  
1/9/2023Brendan TeehanCOOSell532$17.13$9,113.164,549View SEC Filing Icon  
1/9/2023Stephen R. DavisCEOSell3,904$17.13$66,875.5284,633View SEC Filing Icon  
11/21/2022Srdjan R StankovicPresidentSell1,847$15.07$27,834.2961,234View SEC Filing Icon  
10/15/2022Srdjan R StankovicPresidentSell1,326$15.81$20,964.0656,831View SEC Filing Icon  
10/15/2022Stephen R. DavisCEOSell2,804$15.81$44,331.2479,009View SEC Filing Icon  
6/9/2022Mark C. SchneyerCFOSell653$17.91$11,695.233,342View SEC Filing Icon  
5/2/2022Austin D KimEVPSell894$18.18$16,252.9216,742View SEC Filing Icon  
5/2/2022Brendan TeehanCOOSell552$18.18$10,035.363,437View SEC Filing Icon  
5/2/2022Srdjan R StankovicPresidentSell2,865$18.18$52,085.7055,188View SEC Filing Icon  
5/2/2022Stephen R. DavisCEOSell5,483$18.18$99,680.9475,875View SEC Filing Icon  
4/8/2022James KiharainsiderSell1,025$27.05$27,726.252,433View SEC Filing Icon  
2/23/2022Austin D KimEVPSell782$23.80$18,611.60View SEC Filing Icon  
2/23/2022Brendan TeehanCOOSell472$23.80$11,233.60View SEC Filing Icon  
2/23/2022James KiharaInsiderSell359$23.80$8,544.20View SEC Filing Icon  
2/23/2022Srdjan R StankovicPresidentSell1,501$23.80$35,723.80View SEC Filing Icon  
2/23/2022Stephen R. DavisCEOSell3,928$23.80$93,486.40View SEC Filing Icon  
11/22/2021Srdjan R StankovicPresidentSell2,803$19.01$53,285.03View SEC Filing Icon  
10/18/2021Srdjan R StankovicPresidentSell1,338$17.41$23,294.58View SEC Filing Icon  
10/18/2021Stephen R. DavisCEOSell2,963$17.41$51,585.83View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ACADIA Pharmaceuticals (NASDAQ:ACAD)

96.71% of ACADIA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACAD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ACADIA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2024DekaBank Deutsche Girozentrale97,284$1.75M0.0%+2.9%0.059%Search for SEC Filing on Google Icon
5/28/2024Verity Asset Management Inc.11,668$0.22M0.1%N/A0.007%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC15,412$0.29M0.0%N/A0.009%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System108,822$2.01M0.0%-5.2%0.066%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD3,999,550$73.95M0.0%-22.8%2.421%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC26,213$0.48M0.0%+208.6%0.016%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd102,984$1.90M1.8%+243.5%0.062%Search for SEC Filing on Google Icon
5/14/2024Advisors Asset Management Inc.14,256$0.26M0.0%+73.1%0.009%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC4,715$87K0.1%-17.4%0.003%Search for SEC Filing on Google Icon
5/14/2024CM Management LLC40,000$0.74M0.6%+33.3%0.024%Search for SEC Filing on Google Icon
5/14/2024Shell Asset Management Co.7,339$0.14M0.0%+65.7%0.004%Search for SEC Filing on Google Icon
5/14/2024Healthcare of Ontario Pension Plan Trust Fund189,272$3.50M0.0%-59.8%0.115%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP151,171$2.80M0.3%+128.3%0.091%Search for SEC Filing on Google Icon
5/11/2024Covestor Ltd2,032$38K0.0%+70.5%0.001%Search for SEC Filing on Google Icon
5/11/2024Hillsdale Investment Management Inc.157,688$2.92M0.2%+8.6%0.095%Search for SEC Filing on Google Icon
5/11/2024Edgestream Partners L.P.61,906$1.15M0.1%+63.3%0.037%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.13,298,541$245.89M0.0%-0.7%8.050%Search for SEC Filing on Google Icon
5/10/2024Jupiter Asset Management Ltd.1,603,774$29.65M0.3%+21.3%0.971%Search for SEC Filing on Google Icon
5/10/2024M&G Plc312,325$5.62M0.0%N/A0.189%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System39,881$0.75M0.0%+15.3%0.024%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC33,583$0.62M0.0%+10.0%0.020%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.20,689$0.38M0.0%+12.3%0.013%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC2,601$48K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.34,752$0.64M0.0%+6.2%0.021%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank210,604$3.89M0.0%+0.4%0.127%Search for SEC Filing on Google Icon
5/7/2024Oppenheimer Asset Management Inc.26,715$0.49M0.0%-21.6%0.016%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC84,956$1.57M0.0%+246.7%0.051%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP111,394$2.06M0.2%+730.9%0.067%Search for SEC Filing on Google Icon
5/2/2024Mutual of America Capital Management LLC66,930$1.24M0.0%-5.0%0.041%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB322,504$5.94M0.0%-45.0%0.195%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC11,403$0.21M0.0%N/A0.007%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets120,145$2.22M0.0%-47.7%0.073%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.76,792$1.42M0.0%-10.5%0.046%Search for SEC Filing on Google Icon
4/30/2024Privium Fund Management B.V.148,400$2.74M0.7%N/A0.090%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.84,796$1.57M0.0%-11.9%0.051%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.31,654$0.59M0.1%+66.7%0.019%Search for SEC Filing on Google Icon
4/25/2024WCM Investment Management LLC282,035$5.22M0.0%N/A0.171%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC664,556$12.29M0.7%-4.1%0.403%Search for SEC Filing on Google Icon
4/23/2024Wesbanco Bank Inc.26,800$0.50M0.0%N/A0.016%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC58,846$1.09M0.0%-60.0%0.036%Search for SEC Filing on Google Icon
4/18/2024Diversified Trust Co30,865$0.57M0.0%+6.3%0.019%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.142,998$2.64M0.1%+24.2%0.087%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC67,474$1.25M0.0%+3.5%0.041%Search for SEC Filing on Google Icon
3/29/2024Kapitalo Investimentos Ltda5,796$0.18M0.0%-39.7%0.004%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.13,396,009$419.43M0.0%-1.6%8.130%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC143,054$4.48M0.0%N/A0.087%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC101,000$3.16M0.1%N/A0.062%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC809,391$25.34M0.4%N/A0.493%Search for SEC Filing on Google Icon
2/15/2024Old Well Partners LLC8,208$0.26M0.2%N/A0.005%Search for SEC Filing on Google Icon
2/15/2024Parkwood LLC22,464$0.70M0.1%+10.4%0.014%Search for SEC Filing on Google Icon
2/15/2024Penn Capital Management Company LLC247,324$7.77M0.7%-14.5%0.151%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.730,917$22.89M1.2%+15.9%0.445%Search for SEC Filing on Google Icon
2/15/2024Bridger Management LLC117,341$3.67M1.4%N/A0.071%Search for SEC Filing on Google Icon
2/15/2024Comerica Bank42,297$1.32M0.0%+9,601.1%0.026%Search for SEC Filing on Google Icon
2/14/2024Frontier Capital Management Co. LLC823,586$25.79M0.3%+8.7%0.502%Search for SEC Filing on Google Icon
2/14/2024Lighthouse Investment Partners LLC46,484$1.46M0.1%N/A0.028%Search for SEC Filing on Google Icon
2/14/2024Capital Fund Management S.A.243,812$7.63M0.0%+38.8%0.149%Search for SEC Filing on Google Icon
2/14/2024Seven Eight Capital LP66,207$2.07M0.2%+15.5%0.040%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP11,253,551$352.35M5.5%-2.8%6.854%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.15,060$0.47M0.2%-92.8%0.009%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP1,777,307$55.65M0.1%+9.1%1.083%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC427,930$13.40M0.1%+27.1%0.261%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company846,028$26.49M0.0%-19.5%0.515%Search for SEC Filing on Google Icon
2/13/2024Finepoint Capital LP769,653$24.10M6.9%+38.3%0.469%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC67,342$2.11M0.2%N/A0.041%Search for SEC Filing on Google Icon
2/12/2024Alpha DNA Investment Management LLC16,510$0.52M0.2%N/A0.010%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc206,496$6.47M0.0%-8.5%0.126%Search for SEC Filing on Google Icon
2/9/2024Affinity Investment Advisors LLC9,287$0.29M0.2%N/A0.006%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP52,521$1.64M0.3%+248.6%0.032%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.50,405$1.58M0.0%+1.6%0.031%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC1,253$39K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP42,144$1.32M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/9/2024Hillsdale Investment Management Inc.145,158$4.55M0.4%+8.5%0.088%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG307,359$9.62M0.0%+112.4%0.187%Search for SEC Filing on Google Icon
2/9/2024BI Asset Management Fondsmaeglerselskab A S3,186$100K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd18,870$0.59M0.1%+46.6%0.011%Search for SEC Filing on Google Icon
2/9/2024Norges Bank1,443,218$45.19M0.0%N/A0.879%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.644,920$20.19M0.1%+0.3%0.393%Search for SEC Filing on Google Icon
2/8/2024EFG Asset Management North America Corp.46,979$1.47M0.3%+17.8%0.029%Search for SEC Filing on Google Icon
2/8/2024Empire Life Investments Inc.174,815$5.47M0.4%+0.3%0.106%Search for SEC Filing on Google Icon
2/8/2024M&G Investment Management Ltd.333,824$10.35M0.1%N/A0.203%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA60,564$1.90M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.96,214$3.01M0.0%+23.1%0.059%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC116,341$3.64M0.1%+326.3%0.071%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets229,765$7.19M0.0%-24.7%0.140%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas24,624$0.77M0.0%-18.1%0.015%Search for SEC Filing on Google Icon
2/7/2024Van Hulzen Asset Management LLC78,650$2.46M0.2%+48.2%0.048%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.22,893$0.72M0.0%+32.4%0.014%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,127,907$35.32M0.0%+5.1%0.687%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank17,461$0.55M0.0%-6.6%0.011%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC65,179$2.04M0.0%+43.9%0.040%Search for SEC Filing on Google Icon
2/6/2024Natixis Advisors L.P.40,875$1.28M0.0%+17.6%0.025%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank209,804$6.57M0.0%-9.7%0.128%Search for SEC Filing on Google Icon
2/6/2024Fisher Asset Management LLC143,054$4.48M0.0%N/A0.087%Search for SEC Filing on Google Icon
2/6/2024New York Life Investment Management LLC18,351$0.58M0.0%-2.8%0.011%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.98,353$3.08M0.0%-1.2%0.060%Search for SEC Filing on Google Icon
2/5/2024Mach 1 Financial Group LLC14,726$0.46M0.2%N/A0.009%Search for SEC Filing on Google Icon
2/5/2024Sector Gamma AS188,111$5.89M1.4%+4.6%0.115%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.18,425$0.58M0.0%-94.3%0.011%Search for SEC Filing on Google Icon
2/2/2024Truist Financial Corp63,926$2M0.0%-33.9%0.039%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ACADIA Pharmaceuticals logo
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.
Read More on ACADIA Pharmaceuticals

Today's Range

Now: $14.91
Low: $14.81
High: $15.12

50 Day Range

MA: $16.03
Low: $14.62
High: $18.15

52 Week Range

Now: $14.91
Low: $14.55
High: $33.99

Volume

1,488,139 shs

Average Volume

1,423,540 shs

Market Capitalization

$2.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top insider investors include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Austin D Kim (EVP)
  5. Brendan Teehan (COO)
  6. Mark C Schneyer (CFO)
  7. James Kihara (Insider)
  8. Laura Brege (Director)
Learn More about top insider investors at ACADIA Pharmaceuticals.

Who are the major institutional investors of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 8.05%
  2. Price T Rowe Associates Inc. MD — 2.42%
  3. Jupiter Asset Management Ltd. — 0.97%
  4. Rice Hall James & Associates LLC — 0.40%
  5. Nordea Investment Management AB — 0.20%
  6. M&G Plc — 0.19%
Learn More about top institutional investors of ACADIA Pharmaceuticals stock.

Which institutional investors are selling ACADIA Pharmaceuticals stock?

In the last quarter, ACAD stock was sold by these institutional investors:
  1. Price T Rowe Associates Inc. MD
  2. Healthcare of Ontario Pension Plan Trust Fund
  3. Nordea Investment Management AB
  4. BNP Paribas Financial Markets
  5. Vanguard Group Inc.
  6. Allspring Global Investments Holdings LLC
  7. Torno Capital LLC
  8. Rice Hall James & Associates LLC
During the previous year, company insiders that have sold ACADIA Pharmaceuticals company stock include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Austin D Kim (EVP)
  5. Brendan Teehan (COO)
Learn More investors selling ACADIA Pharmaceuticals stock.

Which institutional investors are buying ACADIA Pharmaceuticals stock?

During the previous quarter, ACAD stock was purchased by institutional investors including:
  1. M&G Plc
  2. WCM Investment Management LLC
  3. Jupiter Asset Management Ltd.
  4. Privium Fund Management B.V.
  5. GSA Capital Partners LLP
  6. Seven Eight Capital LP
  7. Twin Tree Management LP
  8. Nan Fung Group Holdings Ltd